血浆线粒体相关蛋白水平与疑似脓毒症病情严重程度相关并预测结局
该研究为Acutelines数据生物库的事后分析,纳入213例急诊疑似脓毒症且感染经独立裁定确认的成人患者,用Olink Explore HT平台定量血浆蛋白,从5,416种蛋白中选取232种线粒体相关蛋白(MitoCarta3.0)经z标准化后取均值得到连续线粒体蛋白评分。结果显示评分随病情严重程度升高(Spearman ρ 0.18-0.29,p<0.01),并与72小时不良结局相关(每SD:无器官衰竭生存OR 0.57;ICU入住OR 1.66;死亡OR 2.36)。探索性聚类仅发现两组主要差异为整体蛋白丰度,重叠明显,支持连续谱而非离散亚型。结论仅为假说生成。
要点
- 在213例急诊疑似脓毒症且感染经独立裁定确认的成人中,线粒体相关蛋白评分每升高1个SD,72小时死亡OR为2.36。
- 同一评分每升高1个SD,72小时无器官衰竭生存OR为0.57,ICU入住OR为1.66。
- 评分与病情严重程度呈弱至中度正相关(Spearman ρ 0.18-0.29,p<0.01)。
- 探索性聚类未支持存在离散线粒体亚型,蛋白丰度变化呈连续谱。
适用人群与场景
- 急诊就诊的成人疑似脓毒症患者,且感染经独立裁定确认;来自Acutelines数据生物库的事后分析。
- 原文未提及排除人群、院前或ICU场景、病情阶段的具体限定。
诊断标准与关键阈值
- 原文未提及脓毒症诊断标准、评分界值或启动/停止阈值。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及红旗征或需要立刻处理的情况。
研究设计与关键结果
- 研究类型:Acutelines数据生物库的事后分析;样本量213例成人;单中心(原文未明确中心数,但为数据生物库)。
- 干预/暴露:用Olink Explore HT平台定量血浆蛋白,从5,416种蛋白中选取232种线粒体相关蛋白(MitoCarta3.0),z标准化后取均值得到连续线粒体蛋白评分。
- 主要终点结果:评分与病情严重程度相关(Spearman ρ 0.18-0.29,p<0.01);每升高1个SD,72小时无器官衰竭生存OR 0.57,ICU入住OR 1.66,死亡OR 2.36。
- 探索性聚类:识别出两组主要差异为整体线粒体相关蛋白丰度,但重叠明显、对离散两簇结构支持有限,提示连续谱而非明确亚型。
- 探索性通路分析提示线粒体代谢、细胞应激和损伤相关过程。
- 不良事件:原文未提及。
证据类型、等级与局限
- 证据类型:单中心(数据生物库)事后分析、观察性研究;证据等级或推荐强度原文未提及。
- 局限:事后分析、样本量213例、探索性分析、假说生成性质;原文未提及其他局限。
对床旁实践的改变
- 原文未提及对急诊/ICU具体实践的改变;结论仅为假说生成,不能用于床旁决策或常规检测。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Mitochondrial dysfunction has been implicated in sepsis-related organ failure. We investigated whether plasma profiles of mitochondrial-associated proteins are associated with illness severity and short-term outcomes and explored whether they reveal distinct mitochondrial subphenotypes.
METHODS: In this post hoc analysis of the Acutelines data-biobank, we included 213 adult patients presenting to the emergency department with a suspicion of sepsis, with infection confirmed by independent adjudication. Blood plasma proteins of patients were quantified with the Olink Explore HT platform; of 5,416 proteins, 232 mitochondrial-associated proteins (MitoCarta3.0) were z-standardized and averaged per patient to derive a continuous mitochondrial-protein score. To explore whether operationally distinct patient groups could be identified along this gradient, we additionally performed principal component analysis with K-means clustering on the same protein set. Differential abundance analysis, pathway enrichment, and least absolute shrinkage and selection operator regression were performed as exploratory analyses.
RESULTS: The continuous mitochondrial-associated protein score increased with illness severity (Spearman ρ 0.18-0.29; p < 0.01) and worse 72-hour outcomes (odds ratio per standard deviation: organ failure-free survival 0.57; intensive care unit admission 1.66; mortality 2.36). Exploratory clustering identified two groups differing mainly in overall mitochondrial-associated protein abundance. Considerable overlap and limited support for a discrete two-cluster structure suggested variation along a continuum rather than clearly distinct mitochondrial subphenotypes. Exploratory pathway analyses implicated mitochondrial metabolism, cellular stress, and injury-related processes.
CONCLUSIONS: Higher plasma mitochondrial-associated protein abundance was associated with greater illness severity and worse short-term outcomes in suspected sepsis. These associations are hypothesis-generating, providing a first step toward understanding the role of mitochondrial dysfunction in sepsis severity.
参考来源
- Meems CJ, van Beuningen FE, Coenen BA, et al. Plasma mitochondrial-associated proteins scale with illness severity and predict outcome in suspected sepsis. Crit Care. 2026. PMID: 42806380. doi:10.1186/s13054-026-06291-4
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。